The value of adjunctive radiotherapy when chemotherapy is the major curative method.

[1]  R. Arriagada,et al.  Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer. , 1990, International journal of radiation oncology, biology, physics.

[2]  R. Arriagada,et al.  Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group. , 1990, International journal of radiation oncology, biology, physics.

[3]  R. Arriagada,et al.  Thoracic radiotherapy in small cell lung cancer: rationale for timing and fractionation , 1989 .

[4]  M. Tubiana,et al.  The combination of radiotherapy and chemotherapy: a review. , 1989, International journal of radiation biology.

[5]  R. Arriagada,et al.  Limited small cell lung cancer: possible prognostic impact of initial chemotherapy doses. , 1989, Bulletin du cancer.

[6]  J. Bergh,et al.  A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four‐drug chemotherapy regimens , 1988, Cancer.

[7]  A. Turrisi,et al.  A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. , 1988, International journal of radiation oncology, biology, physics.

[8]  R. Arriagada,et al.  Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  M. Sklar.  The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. , 1988, Science.

[10]  W. Degraff,et al.  Chinese hamster pleiotropic multidrug-resistant cells are not radioresistant. , 1988, NCI monographs : a publication of the National Cancer Institute.

[11]  M. Héry,et al.  Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement. , 1988, Bulletin du cancer.

[12]  R. Arriagada,et al.  Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients. , 1988, NCI monographs : a publication of the National Cancer Institute.

[13]  G. Steel.  The search for therapeutic gain in the combination of radiotherapy and chemotherapy. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  N. Choi,et al.  A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B Study. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Namer,et al.  Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  R. Makuch,et al.  Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. , 1987, Annals of internal medicine.

[17]  J. Ware,et al.  Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. , 1987, The New England journal of medicine.

[18]  J. Crowley,et al.  Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Band,et al.  Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung. , 1986, Seminars in oncology.

[20]  J. Crowley,et al.  Concurrent chemotherapy and radiotherapy for limited small-cell carcinoma of the lung: a Southwest Oncology Group Study. , 1986, Seminars in oncology.

[21]  Y. Hiraki,et al.  Randomized trial comparing chemotherapy alone and chemotherapy plus chest irradiation in limited stage small cell lung cancer: a preliminary report. , 1986, Japanese journal of clinical oncology.

[22]  H. Hansen,et al.  Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up. , 1986, British Journal of Cancer.

[23]  K. Wallner,et al.  Adriamycin resistance, heat resistance and radiation response in Chinese hamster fibroblasts. , 1986, International journal of radiation oncology, biology, physics.

[24]  C. Perez,et al.  Impact of tumor control on survival in carcinoma of the lung treated with irradiation. , 1986, International journal of radiation oncology, biology, physics.

[25]  H D Suit,et al.  Impact of improved local control on survival. , 1986, International journal of radiation oncology, biology, physics.

[26]  V. Devita,et al.  The effect of combined modality therapy on local control and survival. , 1986, International journal of radiation oncology, biology, physics.

[27]  R. Makuch,et al.  Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Gospodarowicz,et al.  Role of radiation therapy in localized non-Hodgkin's lymphoma. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  R. Arriagada,et al.  Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. , 1985, International journal of radiation oncology, biology, physics.

[30]  R. Arriagada,et al.  Sequencing of drugs and radiation. The integrated alternating regimen , 1985, Cancer.

[31]  K. Fu.  Biological basis for the interaction of chemotherapeutic agents and radiation therapy , 1985, Cancer.

[32]  M. Tubiana,et al.  An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  F. Cabanillas.  Chemotherapy as definitive treatment of stage I‐II large cell and diffuse mixed lymphomas , 1985, Hematological oncology.

[34]  H. Cohen,et al.  Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  J. Jacobs,et al.  Correlation between response to cisplatinum‐combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck , 1984, Cancer.

[36]  J H Goldie,et al.  The genetic origin of drug resistance in neoplasms: implications for systemic therapy. , 1984, Cancer research.

[37]  R. Souhami,et al.  Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. , 1984, British medical journal.

[38]  H. Hansen,et al.  Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung. , 1984, Cancer Treatment Reviews.

[39]  Skipper He,et al.  Tumor stem cell heterogeneity: implications with respect to classification of cancers by chemotherapeutic effect. , 1984 .

[40]  G E Hanks,et al.  Patterns of care study: Hodgkin's disease relapse rates and adequacy of portals , 1983, Cancer.

[41]  V. Devita.  The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer , 1983, Cancer.

[42]  Timothy Chen,et al.  The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a Southwest Oncology group study , 1982, Cancer.

[43]  M. Tattersall,et al.  A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. , 1980, International journal of radiation oncology, biology, physics.

[44]  G. Fletcher.  Clinical dose-response curves of human malignant epithelial tumours. , 1973, The British journal of radiology.